Recent advances in nanotheranostics for triple negative breast cancer treatment
Abstract Triple-negative breast cancer (TNBC) is the most complex and aggressive type of breast cancer encountered world widely in women. Absence of hormonal receptors on breast cancer cells necessitates the chemotherapy as the only treatment regime. High propensity to metastasize and relapse in add...
Main Authors: | Vikram Thakur, Rajaletchumy Veloo Kutty |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-10-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1443-1 |
Similar Items
-
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
by: Mauricio A. Medina, et al.
Published: (2020-03-01) -
Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities
by: Panoraia I. Siafaka, et al.
Published: (2021-01-01) -
Cancer Nanotheranostics: What Have We Learned So Far?
Published: (2016) -
Global trends in nanomedicine research on triple negative breast cancer: a bibliometric analysis
by: Teles RHG, et al.
Published: (2018-04-01) -
Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment
by: Hao Cai, et al.
Published: (2021-02-01)